TET2 and posterior cortical atrophy: By integrating TET2 status into interpretable nomograms with validated clinical utility via DCA, these computational frameworks establish TET2 not merely as a biomarker but as a dynamic predictor capable of refining personalized risk stratification in TZ PCa.